| Primary |
| Chronic Obstructive Pulmonary Disease |
47.0% |
| Asthma |
13.9% |
| Hypertension |
9.8% |
| Emphysema |
6.0% |
| Blood Cholesterol Increased |
3.2% |
| Dyspnoea |
2.7% |
| Anxiety |
2.0% |
| Diabetes Mellitus |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hypothyroidism |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Cardiac Disorder |
1.3% |
| Bronchitis Chronic |
1.3% |
| Depression |
1.2% |
| Prophylaxis |
1.1% |
| Bronchitis |
1.1% |
| Back Pain |
1.0% |
| Supplementation Therapy |
0.9% |
| Cardiac Failure Congestive |
0.9% |
| Hypersensitivity |
0.8% |
|
| Drug Ineffective |
19.5% |
| Dyspnoea |
13.4% |
| Off Label Use |
12.8% |
| Product Quality Issue |
9.4% |
| Dysgeusia |
6.5% |
| Overdose |
4.6% |
| Pneumonia |
4.3% |
| Wheezing |
3.9% |
| Drug Prescribing Error |
3.8% |
| Throat Irritation |
3.5% |
| Prescribed Overdose |
3.4% |
| Drug Effect Decreased |
2.7% |
| Death |
1.9% |
| Tremor |
1.7% |
| Pulmonary Congestion |
1.6% |
| Retching |
1.6% |
| Cough |
1.4% |
| Oropharyngeal Pain |
1.4% |
| Therapeutic Response Decreased |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
42.1% |
| Asthma |
14.8% |
| Emphysema |
9.2% |
| Hypertension |
6.4% |
| Product Used For Unknown Indication |
4.7% |
| Dyspnoea |
3.8% |
| Blood Cholesterol Increased |
2.5% |
| Bronchitis |
2.2% |
| Drug Use For Unknown Indication |
2.1% |
| Bronchitis Chronic |
1.9% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Hypothyroidism |
1.5% |
| Anxiety |
1.3% |
| Atrial Fibrillation |
1.3% |
| Diabetes Mellitus |
0.9% |
| Cough |
0.9% |
| Depression |
0.9% |
| Fluid Retention |
0.7% |
| Hypersensitivity |
0.7% |
| Arthritis |
0.6% |
|
| Drug Ineffective |
15.9% |
| Dyspnoea |
15.0% |
| Off Label Use |
11.8% |
| Product Quality Issue |
9.2% |
| Pneumonia |
7.2% |
| Overdose |
6.0% |
| Wheezing |
5.5% |
| Tremor |
3.1% |
| Throat Irritation |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Death |
2.5% |
| Prescribed Overdose |
2.5% |
| Pulmonary Congestion |
2.3% |
| Vision Blurred |
2.3% |
| Mesothelioma |
2.0% |
| Vomiting |
2.0% |
| Drug Effect Decreased |
1.9% |
| Dysgeusia |
1.8% |
| Lung Infection |
1.8% |
| Oropharyngeal Pain |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.4% |
| Drug Use For Unknown Indication |
14.5% |
| Chronic Obstructive Pulmonary Disease |
13.4% |
| Asthma |
11.1% |
| Hypertension |
5.4% |
| Pain |
4.4% |
| Dyspnoea |
3.3% |
| Depression |
3.3% |
| Emphysema |
3.2% |
| Smoking Cessation Therapy |
2.4% |
| Diabetes Mellitus |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Non-small Cell Lung Cancer |
2.1% |
| Anxiety |
1.8% |
| Osteoporosis |
1.7% |
| Blood Cholesterol Increased |
1.5% |
| Hypersensitivity |
1.4% |
| Prophylaxis |
1.3% |
| Nausea |
1.2% |
|
| Vomiting |
9.1% |
| Dyspnoea |
8.7% |
| Pneumonia |
7.7% |
| Drug Ineffective |
7.7% |
| Weight Decreased |
7.7% |
| Weight Increased |
6.0% |
| Wheezing |
5.8% |
| Nausea |
5.0% |
| Death |
4.9% |
| Myocardial Infarction |
4.5% |
| Product Quality Issue |
4.4% |
| Respiratory Failure |
3.9% |
| Vision Blurred |
3.8% |
| Pharmaceutical Product Complaint |
3.5% |
| Tremor |
3.5% |
| Type 2 Diabetes Mellitus |
3.4% |
| Urinary Tract Infection |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Pain |
2.5% |
| Rash |
2.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
46.5% |
| Asthma |
14.0% |
| Hypertension |
7.0% |
| Smoking Cessation Therapy |
7.0% |
| Depression |
4.7% |
| Diabetes Mellitus |
4.7% |
| Pain |
4.7% |
| Atrial Fibrillation |
2.3% |
| Dyspnoea |
2.3% |
| Emphysema |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Hypothyroidism |
2.3% |
|
| Urinary Tract Infection |
28.6% |
| Bradycardia |
14.3% |
| Nausea |
14.3% |
| Overdose |
14.3% |
| Pulmonary Oedema |
14.3% |
| Wheezing |
14.3% |
|
